NFKB1 and acute myeloid leukemia: Both AML cells and stromal cells release several extracellular matrix (ECM) molecules, and several ECM (derived) molecules can function as endogenous TLR4 ligands and thereby influence the function of the downstream CK2 target NFκB [76].